-
4 Things To Know About Akebia's New Vadadustat Collaboration With Otsuka Pharma
Thursday, April 27, 2017 - 11:05am | 559Following Akebia Therapeutics Inc's (NASDAQ: AKBA) announcement of an expanded agreement with Otsuka (OTC: OTSKY) to develop and commercialize Vadadustat in Europe, China and Other Territories, HC Wainwright said in a note that the European partnership provides strong economics, removing any...